)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
60 Degrees Pharmaceuticals (SCTP) investor relations material
60 Degrees Pharmaceuticals Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary13 Nov, 2025
Executive summary
Q3 2025 net product revenue increased 223% year-over-year to $438K, driven by restocking in the U.S. supply chain, growth in Australia and Europe, and expanded ARAKODAⓇ deliveries.
Gross margin turned negative at -22.9% due to significant inventory write-offs from scaling up production, expected to be non-recurring.
Research revenues rose sharply to $90,960 in Q3 2025, reflecting new government contracts.
Operating expenses increased to $2.32M, mainly from higher sales, advertising, and legal costs.
Net loss attributed to common stockholders was $2.44M for Q3 2025, or $(0.66) per share.
Financial highlights
Product revenues for the nine months ended September 30, 2025, were $702,086, up 92% year-over-year.
Gross margin for the nine months was 5.9%, down from 27.1% in the prior year, due to inventory write-offs.
Research and development expenses decreased 67% year-over-year for the nine months, mainly due to prior year non-cash charges.
General and administrative expenses rose 41% year-over-year for the nine months, driven by increased marketing and investor outreach.
Net cash used in operating activities was $5.16M for the nine months, up 29% year-over-year.
Cash and cash equivalents at September 30, 2025, were $4.1M.
ARAKODAⓇ pharmacy deliveries grew 14% year-over-year to 1,505 boxes.
Outlook and guidance
Management estimates current cash will fund operations through March 31, 2026, absent additional capital raises.
Additional lots with a four-year shelf-life are in production and expected to enter the supply chain in early Q1 2026.
The company expects to need further capital to support commercial and clinical activities and cannot assure future profitability.
The company is seeking FDA MUMS designation for acute canine babesiosis and expanding research into new indications for tafenoquine.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next 60 Degrees Pharmaceuticals earnings date
Q4 202527 Mar, 2026
Next 60 Degrees Pharmaceuticals earnings date
Q4 202527 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
60 Degrees Pharmaceuticals Inc. is a pharmaceutical company focused on developing and commercializing treatments for infectious diseases, particularly those affecting travelers and people in tropical and subtropical regions. The company’s primary focus is on therapeutics for diseases such as malaria and dengue fever, aiming to address unmet needs in global health. 60 Degrees Pharmaceuticals collaborates with various research organizations and government agencies to advance its product pipeline and expand access to its treatments in underserved regions. The company is headquartered in Washington, D.C., and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage